サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423953

犬用ワクチン市場、シェア、規模、傾向、産業分析レポート：ワクチンタイプ別、疾患タイプ別、投与経路別、免疫期間別、成分別、地域別、セグメント別予測、2024-2032年

Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
犬用ワクチン市場、シェア、規模、傾向、産業分析レポート：ワクチンタイプ別、疾患タイプ別、投与経路別、免疫期間別、成分別、地域別、セグメント別予測、2024-2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の犬用ワクチン市場規模は2032年までに27億828万米ドルに達する見込みです。このレポートは現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

犬用ワクチン市場は、ペットの健康や広範な動物用医薬品産業の重要性の高まりを裏付ける要因が重なり、近年大きな成長を遂げています。この市場拡大の原動力のひとつは、犬の様々な病気を予防するワクチン接種の利点に対する飼い主の意識の高まりです。より多くの人々が犬の病気に関連する潜在的なリスクについて知るようになり、これらの健康上の脅威から愛するペットを守ることができる効果的なワクチンに対する需要が高まっています。

さらに、獣医学研究と技術の進歩により、有効性と安全性が向上した革新的なワクチンの開発が促進されています。これにより、予防できる病気の範囲が広がっただけでなく、犬の医療全体の質も向上しました。獣医の専門家は、年齢、犬種、ライフスタイルなどの要因を考慮し、個々の犬のユニークなニーズに対応したオーダーメイドのワクチン接種プロトコルを提供するために、これまで以上に優れた能力を備えています。

さらに、規制当局のイニシアチブと公衆衛生キャンペーンは、犬用ワクチン市場のダイナミクスを形成する上で極めて重要な役割を果たしています。世界中の政府機関や獣医師会は、責任あるペットの飼育を積極的に推進し、予防医療の基礎として定期的なワクチン接種の重要性を強調してきました。このような協調的な努力は、より有利な規制環境と動物用ワクチン分野の研究開発に対する公的資金の増加に寄与しています。

さらに、ペットの人間化の動向の高まりは、犬の幸福と長寿を保証するワクチンを含む高度な医療ソリューションへの需要をさらに押し上げています。ペットの飼い主は、イヌの仲間を家族の重要な一員とみなすようになってきており、そのため、イヌがより健康的な生活を送れるような予防対策への投資を厭わなくなってきています。ペットを家族の一員として扱うというこの文化的変化は、ワクチンメーカーに有利な市場機会を生み出し、絶え間ない技術革新と製品開発を特徴とする競争情勢を育んでいます。

犬用ワクチン市場レポートハイライト

病気の予防に役立ち、長期的な免疫を提供することから、弱毒化ワクチンセグメントが市場を独占

狂犬病セグメントは、主にその高い有病率と人獣共通感染症の可能性により、急速なペースで成長すると思われます。

APAC地域は、ペットの数が多く、飼い主の意識が高まっていることから、最も速いペースで成長します。

目次

第1章 イントロダクション

  • レポートの説明
    • 研究の目的
    • 市場範囲
    • 仮定
  • 利害関係者

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の犬用ワクチン市場に関する洞察

  • 犬用ワクチン市場- 免疫期間のスナップショット
  • 犬用ワクチン市場力学
    • 促進要因と機会
      • ペットの普及率の向上
      • 獣医学の進歩
    • 抑制要因と課題
      • ワクチンの高コスト
  • PESTEL分析
  • 犬用ワクチン市場の免疫期間の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の犬用ワクチン市場、疾患タイプ別

  • 主な調査結果
  • イントロダクション
  • 犬ジステンパー
  • 犬感染性呼吸器疾患複合体（CIRDC）
  • 犬パルボウイルス症/パルボウイルス病
  • 犬レプトスピラ症
  • 犬のライム病
  • 犬伝染性肝炎
  • 狂犬病
  • その他

第6章 世界の犬用ワクチン市場、ワクチンタイプ別

  • 主な調査結果
  • イントロダクション
  • 変性/弱毒化生
  • 不活性化（不活化）
  • その他

第7章 世界の犬用ワクチン市場、免疫期間別

  • 主な調査結果
  • イントロダクション
  • 1年
  • 3年
  • その他

第8章 世界の犬用ワクチン市場、地域別

  • 主な調査結果
  • イントロダクション
    • 犬用ワクチン市場評価、地域別、2019-2032年
  • 犬用ワクチン市場-北米
    • 北米：犬用ワクチン市場、疾患タイプ別、2019-2032年
    • 北米：犬用ワクチン市場、免疫期間別、2019-2032年
    • 北米：犬用ワクチン市場、ワクチンタイプ別、2019-2032年
    • 犬用ワクチン市場-米国
    • 犬用ワクチン市場- カナダ
  • 犬用ワクチン市場- 欧州
    • 欧州：犬用ワクチン市場、疾患タイプ別、2019～2032年
    • 欧州：犬用ワクチン市場、免疫期間別、2019-2032年
    • 欧州：犬用ワクチン市場、ワクチンタイプ別、2019～2032年
    • 犬用ワクチン市場- 英国
    • 犬用ワクチン市場- フランス
    • 犬用ワクチン市場- ドイツ
    • 犬用ワクチン市場- イタリア
    • 犬用ワクチン市場- スペイン
    • 犬用ワクチン市場- オランダ
    • 犬用ワクチン市場- ロシア
  • 犬用ワクチン市場- アジア太平洋
    • アジア太平洋：犬用ワクチン市場、疾患タイプ別、2019～2032年
    • アジア太平洋：犬用ワクチン市場、免疫期間別、2019～2032年
    • アジア太平洋：犬用ワクチン市場、ワクチンタイプ別、2019～2032年
    • 犬用ワクチン市場- 中国
    • 犬用ワクチン市場- インド
    • 犬用ワクチン市場- マレーシア
    • 犬用ワクチン市場- 日本
    • 犬用ワクチン市場- インドネシア
    • 犬用ワクチン市場- 韓国
  • 犬用ワクチン市場-中東およびアフリカ
    • 中東およびアフリカ：犬用ワクチン市場、疾患タイプ別、2019～2032年
    • 中東およびアフリカ：犬用ワクチン市場、免疫期間別、2019-2032年
    • 中東およびアフリカ：犬用ワクチン市場、ワクチンタイプ別、2019～2032年
    • 犬用ワクチン市場- サウジアラビア
    • 犬用ワクチン市場- アラブ首長国連邦
    • 犬用ワクチン市場- イスラエル
    • 犬用ワクチン市場- 南アフリカ
  • 犬用ワクチン市場-ラテンアメリカ
    • ラテンアメリカ：犬用ワクチン市場、疾患タイプ別、2019-2032年
    • ラテンアメリカ：犬用ワクチン市場、免疫期間別の犬用ワクチン市場、2019-2032
    • ラテンアメリカ：犬用ワクチン市場、ワクチンタイプ別、2019-2032年
    • 犬用ワクチン市場- メキシコ
    • 犬用ワクチン市場- ブラジル
    • 犬用ワクチン市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Bioveta a.s
  • .Hester Biosciences Limited
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma
  • Heska Corporation
  • Merck & Co., Inc.
  • Virbac
  • Zendal Group
  • Elanco
  • Zoetis Services
図表

List of Tables

  • Table 1 Global Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 2 Global Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 3 Global Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 4 Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 6 North America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 7 North America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 8 U.S.: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 11 Canada: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 12 Canada: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 13 Canada: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 14 Europe: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 15 Europe: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 16 Europe: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 17 UK: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 18 UK: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 19 UK: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 20 France: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 21 France: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 22 France: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 23 Germany: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 24 Germany: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 25 Germany: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 26 Italy: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 27 Italy: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 28 Italy: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 29 Spain: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 30 Spain: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 31 Spain: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 32 Netherlands: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 35 Russia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 36 Russia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 37 Russia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 41 China: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 42 China: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 43 China: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 44 India: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 45 India: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 46 India: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 47 Malaysia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 50 Japan: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 51 Japan: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 52 Japan: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 53 Indonesia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 56 South Korea: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 65 UAE: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 66 UAE: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 67 UAE: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 68 Israel: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 69 Israel: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 70 Israel: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 71 South Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 74 Latin America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 77 Mexico: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 80 Brazil: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 83 Argentina: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Dog Vaccine Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Vaccine Type
  • Figure 7. Global Dog Vaccine Market, by Vaccine Type, 2022 & 2032 (USD Million)
  • Figure 8. Market by Disease Type
  • Figure 9. Global Dog Vaccine Market, by Disease Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by Duration of Immunity
  • Figure 11. Global Dog Vaccine Market, by Duration of Immunity, 2022 & 2032 (USD Million)
  • Figure 12. Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Dog Vaccine Market
目次
Product Code: PM4185

The global dog vaccine market size is expected to reach USD 2,708.28 million by 2032, according to a new study by Polaris Market Research. The report "Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The dog vaccine market has experienced significant growth in recent years, driven by a combination of factors that underscore the increasing importance of pet health and the broader veterinary pharmaceutical industry. One of the primary driving forces behind this expansion is the rising awareness among pet owners about the benefits of vaccination in preventing various diseases in dogs. As more individuals become informed about the potential risks associated with canine illnesses, there is a heightened demand for effective vaccines that can safeguard their beloved pets from these health threats.

Furthermore, advancements in veterinary research and technology have facilitated the development of innovative vaccines with improved efficacy and safety profiles. This has not only expanded the range of diseases that can be prevented but also enhanced the overall quality of canine healthcare. Veterinary professionals are now better equipped than ever to provide tailored vaccination protocols that address the unique needs of individual dogs, considering factors such as age, breed, and lifestyle.

Additionally, regulatory initiatives and public health campaigns have played a pivotal role in shaping the dynamics of the dog vaccine market. Governmental organizations and veterinary associations across the globe have been actively promoting responsible pet ownership and emphasizing the importance of regular vaccinations as a cornerstone of preventive healthcare. These concerted efforts have contributed to a more favorable regulatory environment and increased public funding for research and development in the veterinary vaccine sector.

Moreover, the growing trend of humanization of pets has further propelled the demand for advanced healthcare solutions, including vaccines, to ensure the well-being and longevity of dogs. Pet owners are increasingly viewing their canine companions as integral members of their families and are therefore willing to invest in preventive measures that can help them lead healthier lives. This cultural shift towards treating pets as family members has created a lucrative market opportunity for vaccine manufacturers and has fostered a competitive landscape characterized by continuous innovation and product development.

Dog Vaccine Market Report Highlights

Attenuated vaccine segment dominated the market, as it helps in preventing disease and provides long term immunity

Canine rabies segment will grow at the rapid pace, primarily due to its high prevalence rate, and its zoonotic potential

APAC to grow at the fastest rate, owing to the presence of large number of pets in the region and growing awareness among pet owners

The global players include Bioveta, Hester Biosciences, Boehringer Ingelheim, Brilliant Bio Pharma, Heska Corp., Merck, Virbac, Elanco, and Zoetis Services

Polaris Market Research has segmented the dog vaccine market report based on vaccine type, disease type, duration of immunity, and region:

Dog Vaccine, Vaccine Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Modified/ Attenuated Live
  • Inactivated (Killed)
  • Others

Dog Vaccine, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Canine Distemper
  • Canine Infectious Respiratory Disease Complex (CIRDC)
  • Canine Parvovirosis/ Parvovirus Disease
  • Canine Leptospirosis
  • Canine Lyme Disease
  • Infectious Canine Hepatitis
  • Canine Rabies
  • Others

Dog Vaccine, Duration of Immunity Outlook (Revenue - USD Million, 2019 - 2032)

  • 1-Year
  • 3-Year
  • Others

Dog Vaccine, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dog Vaccine Market Insights

  • 4.1. Dog Vaccine Market - Duration of Immunity Snapshot
  • 4.2. Dog Vaccine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Pet Adoption Rates
      • 4.2.1.2. Advancements in Veterinary Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Vaccines
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dog Vaccine Market Duration of Immunity Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dog Vaccine Market, by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • 5.3. Canine Distemper
    • 5.3.1. Global Dog Vaccine Market, by Canine Distemper, by Region, 2019-2032 (USD Million)
  • 5.4. Canine Infectious Respiratory Disease Complex (CIRDC)
    • 5.4.1. Global Dog Vaccine Market, by Canine Infectious Respiratory Disease Complex (CIRDC), by Region, 2019-2032 (USD Million)
  • 5.5. Canine Parvovirosis/ Parvovirus Disease
    • 5.5.1. Global Dog Vaccine Market, by Canine Parvovirosis/ Parvovirus Disease, by Region, 2019-2032 (USD Million)
  • 5.6. Canine Leptospirosis
    • 5.6.1. Global Dog Vaccine Market, by Canine Leptospirosis, by Region, 2019-2032 (USD Million)
  • 5.7. Canine Lyme Disease
    • 5.7.1. Global Dog Vaccine Market, by Canine Lyme Disease, by Region, 2019-2032 (USD Million)
  • 5.8. Infectious Canine Hepatitis
    • 5.8.1. Global Dog Vaccine Market, by Infectious Canine Hepatitis, by Region, 2019-2032 (USD Million)
  • 5.9. Canine Rabies
    • 5.9.1. Global Dog Vaccine Market, by Canine Rabies, by Region, 2019-2032 (USD Million)
  • 5.10. Others
    • 5.10.1. Global Dog Vaccine Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Dog Vaccine Market, by Vaccine Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 6.3. Modified/ Attenuated Live
    • 6.3.1. Global Dog Vaccine Market, by Modified/ Attenuated Live, by Region, 2019-2032 (USD Million)
  • 6.4. Inactivated (Killed)
    • 6.4.1. Global Dog Vaccine Market, by Inactivated (Killed), by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Dog Vaccine Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Dog Vaccine Market, by Duration of Immunity

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • 7.3. 1-Year
    • 7.3.1. Global Dog Vaccine Market, by 1-Year, By Region, 2019-2032 (USD Million)
  • 7.4. 3-Year
    • 7.4.1. Global Dog Vaccine Market, by 3-Year, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Dog Vaccine Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Dog Vaccine Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Dog Vaccine Market - North America
    • 8.3.1. North America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.3.3. North America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.3.4. Dog Vaccine Market - U.S.
      • 8.3.4.1. U.S.: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.3.5. Dog Vaccine Market - Canada
      • 8.3.5.1. Canada: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.4. Dog Vaccine Market - Europe
    • 8.4.1. Europe: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.4.3. Europe: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.4. Dog Vaccine Market - UK
      • 8.4.4.1. UK: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.5. Dog Vaccine Market - France
      • 8.4.5.1. France: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.5.3. France: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.6. Dog Vaccine Market - Germany
      • 8.4.6.1. Germany: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.7. Dog Vaccine Market - Italy
      • 8.4.7.1. Italy: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.8. Dog Vaccine Market - Spain
      • 8.4.8.1. Spain: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.9. Dog Vaccine Market - Netherlands
      • 8.4.9.1. Netherlands: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.10. Dog Vaccine Market - Russia
      • 8.4.10.1. Russia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.5. Dog Vaccine Market - Asia Pacific
    • 8.5.1. Asia Pacific: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.4. Dog Vaccine Market - China
      • 8.5.4.1. China: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.4.3. China: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.5. Dog Vaccine Market - India
      • 8.5.5.1. India: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.5.3. India: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.6. Dog Vaccine Market - Malaysia
      • 8.5.6.1. Malaysia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.7. Dog Vaccine Market - Japan
      • 8.5.7.1. Japan: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.8. Dog Vaccine Market - Indonesia
      • 8.5.8.1. Indonesia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.9. Dog Vaccine Market - South Korea
      • 8.5.9.1. South Korea: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.6. Dog Vaccine Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.4. Dog Vaccine Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.5. Dog Vaccine Market - UAE
      • 8.6.5.1. UAE: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.6. Dog Vaccine Market - Israel
      • 8.6.6.1. Israel: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.7. Dog Vaccine Market - South Africa
      • 8.6.7.1. South Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.7. Dog Vaccine Market - Latin America
    • 8.7.1. Latin America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.4. Dog Vaccine Market - Mexico
      • 8.7.4.1. Mexico: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.5. Dog Vaccine Market - Brazil
      • 8.7.5.1. Brazil: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.6. Dog Vaccine Market - Argentina
      • 8.7.6.1. Argentina: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bioveta a.s
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Hester Biosciences Limited
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer Ingelheim International GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Brilliant Bio Pharma
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Heska Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck & Co., Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Virbac
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Zendal Group
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Elanco
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Zoetis Services
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development